Pharma News

The latest developments from pharmaceutical and biopharmaceutical companies, both innovator and generic-drug companies, and leading regulatory news.

Merck & Co. reports that the US Food and Drug Administration (FDA) has accepted the company's new drug application for a fixed-dose combination of raltegravir with lamivudine for the treatment of HIV-1 infection. Merck is seeking FDA approval...